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lobal public health is facing significant challenges in terms of emerging and re-emerging pathogens. The 
world is facing a new public health crisis emergence and spread of Coronaviruses outbreaks especially 
COVID-19 after nine deadliest viral outbreaks including Marburg virus, Ebola virus, Rabies, HIV, 
Smallpox, Hantavirus, Influenza, Dengue and Rotavirus. Coronaviruses (enveloped non-segmented positive-
sense RNA viruses) belong to the Coronaviridae family, broadly distributed in humans as well as in other 
mammals. In December 2019, the COVID-19 outbreak was reported in the Wuhan, Hubei province of China. 
WHO confirmed that COVID-19 is associated with Huanan seafood (Wuhan). COVID-19 virus outbreak is more 
dangerous than its ancestors MERS-CoV and SARS-CoV. Although the case fatality rate is lower, it has alarmed 
the world because of its rapid spread during this era of the modern world where the whole world is connected 
through different channels of trade. As the world is already facing economic challenges, underdeveloped 
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Viral outbreaks: A real threat to the world You’re reading 
Introduction  
Outbreaks are usually defined as cases of illnesses that 
occur in the community more frequently than usual. 
Number of cases showing outbreak occurrence depends 
upon the size and type of the population exposed to the 
infectious agent. Viruses are known as major causes of 
the outbreak of foodborne diseases [1]. Emerging 
infectious diseases are the most significant health 
challenge of the 21st century. Among these, the zoonotic 
viruses which originate from the reservoir host and 
transfer to humans and causes the disease syndrome of 
different form and severity. Depending on the capability 
of the emerging virus to transmit in the human 
population, causes individual or some sporadic cases 
which results into localized outbreak or, in worst 
condition large epidemic or a global pandemic. Such type 
of various emergence events occurs in the last two 
decades. They include the viruses that are not previously 
encountered like coronaviruses, severe acute respiratory 
syndrome (SARS), Middle East Respiratory Syndrome 
(MERS) and familiar enemy which have reappeared and 
causes outbreaks like Ebola virus outbreaks [2]. 
Emerging viruses had the capability to cause significant 
mortality, morbidity and economic burdens for humans. 
This review aims for the better understanding of the risks 
and impact of these viral outbreaks (coronaviruses, 
COVID-19, Marburg virus, Ebola virus, Rabies, HIV, 
Smallpox, Hantavirus, Influenza, Dengue, Rotavirus) on 
humans at global level mainly focusing on recent COVID-
19 pandemic which showed inimitable impact all over the 
world.         
Methods 
Literature search strategy and selection criteria 
A systemic search was carried from PubMed, Google 
Scholar, Google Web Browser and World health 
organization reports, by using keywords viral outbreaks, 
coronaviruses, COVID-19, Marburg virus, Ebola virus, 
Rabies, HIV, Smallpox, Hantavirus, Influenza, Dengue, 
Rotavirus. According to the particular contents, further 
literature was screened mainly on the basis that when 
first outbreak of these viruses was reported, total number 
of cases and deaths reported in first outbreak. 
Transmission and economic losses were also reviewed. 
In this study, 126 published articles including World 
Health Organization (WHO) reports were selected to do 
a comprehensive review. 
Discussion 
Corona Viruses   
Novel Corona Virus (COVID-19) 
The world is facing a new public health crisis emergence 
and spread of COVID-19 (coronavirus disease caused 
by 2019-nCoV). Coronaviruses (enveloped non-
segmented positive-sense RNA viruses) belong to the 
Coronaviridae family, broadly distributed in humans as 
well as in other mammals [3]. In December 2019 COVID-
19 outbreak was reported in the Wuhan province of 
China [4], which is subsequently prevalent worldwide. 
Initially, series of pneumonia cases of unknown cause 
was reported in Wuhan, China, WHO named this virus 
2019-nCoV (2019 novel Coronavirus) on 12th January 
2020, later world health organization named this disease 
COVID-19 (coronavirus disease caused by 2019-nCoV) 
officially on 11th February 2020 [5]. WHO confirmed that 
the COVID-19 outbreak was associated with the Huanan 
South China Seafood Marketplace [6]. The novel 
coronavirus (COVID-19) is spreading rapidly from 
Wuhan to the rest of the world [7]. Internationally public 
health emergency declared by WHO on 30 January 
2020, after the emergence of SARS-CoV (severe acute 
respiratory syndrome coronavirus) and MERS-CoV 
(Middle East respiratory syndrome coronavirus) in 2002 
and 2012 respectively, marked the 3rd introduction of 
coronavirus into humans which is highly pathogenic in 
this 21st century [8]. The genome of the COVID-19 was 
published for the first time on 10 January  2020 by a 
research team working under Prof. Yong-Zhen Zhang 
[6]. The National Health Commission of China officially 
announced to include COVID-19 into the management of 
class B legal infectious [6]. This virus (COVID-19) 
originates from bats while its intermediate host is 
pangolins, humans are terminal hosts [9], transmitted 
into humans [10], animals to humans [11], it transmits 
through respiratory droplets by coughing or sneezing. 
The reproduction number of COVID-19 is 2.2. Generally, 
COVID19 is an infectious disease with a 2% case fatality 
rate [12]. Pathologically COVID19 features show great 
resemblance to the SARS-CoV and MERS-CoV 
pathological features [13]. The novel coronavirus 
(COVID-19) spreads faster than SARS-CoV and MERS-
CoV, but low case  fatality rate [14]. The transmissibility 
level of the COVID-19 is higher than SARS-CoV (severe 
acute respiratory syndrome). A severe onset of a disease 
may result in death because of massive alveolar damage 
in the lungs and progressive failure of the respiratory 
system [15]. Symptoms that are reported in case of 
COVID-19 include fever, dyspnea, cough, hemoptysis, 
fatigue, diarrhoea, pneumonia and headache [16]. 
Lymphopenia is common in COVID-19 patients, and it 
may be the critical factor associated with mortality and 
severity of disease [12].   
Total confirmed cases of COVID-19 were 93091 (04 
March 2020) which increases to 972303 (3 April 2020). 
On average, 28361 cases rise daily. At the same time, 
total confirmed cases of COVID-19 were 3198 (04 March 
2020) which grows to 50321 (3 April 2020). On average 
1590 daily deaths were being reported (Figure 1). 
 
Figure 1: Worldwide deaths and cases chart of COVID-19
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As the number of cases increases daily deaths also 
increasing day by day, it indicates that the situation may 
be worsened in the future. 
Transmission  
This virus (2019-nCoV) originates from bats while its 
intermediate host is pangolins, humans are terminal 
hosts [9], transmitted into humans [10], animals to 
humans [11], it transmits through respiratory droplets by 
coughing or sneezing. The reproduction number of 
COVID-19 is 2.2. Generally, COVID19 infection is an 
acute disease with a 2% case fatality rate [12]. 
Pathologically COVID19 features show a remarkable 
resemblance to the SARS-CoV and MERS-CoV 
pathological features [13]. The novel coronavirus (2019-
nCoV) spreads faster than SARS-CoV and MERS-CoV, 
but low case fatality rate [14]. The transmissibility level of 
the COVID-19 is higher than SARS-CoV (severe acute 
respiratory syndrome). A severe onset of a disease may 
result in death because of massive alveolar damage in 
the lungs and progressive failure of the respiratory 
system [15]. Symptoms that are reported in case of 
COVID-19 include fever, dyspnea, cough, hemoptysis, 
fatigue, diarrhoea, pneumonia and headache [16]. 
Lymphopenia is common in COVID-19 patients, and it 
may be the critical factor associated with mortality and 
severity of disease [12].   
MERS-CoV and SARS-CoV  
Global public health is facing significant challenges in 
terms of emerging and re-emerging pathogens[17]. 
Coronaviruses, the enveloped RNA viruses, have a wide 
range of distribution among humans, birds, and other 
mammals leading to respiratory, hepatic, enteric, and 
neurological infections [18]. Due to wide distribution, high 
prevalence of coronaviruses, more genetic diversity, 
recombination of genomes, and enhancing animal-
human interaction, novel coronaviruses may emerge or 
re-emerge periodically. It is more dangerous because of 
the zoonotic importance, trans-species infections, and 
occasionally spillover events [19]. The name coronavirus 
is derived after the crown-like spikes on the surface of 
the virus, these also resemble the corona of the sun, the 
diameter of the virus ranges between 60-140 nm. 
Distinctive spikes on the surface give them a typical 
appearance, the diameter of coronavirus spikes varies 
from 9-12 nm [18]. The genome organization of all 
coronaviruses is similar, while gene replicates 
circumscribe the 5ʹ sixty percent of the genome and is 
made up of two open reading frames (ORFs). These 
frames are ‘ORF1a’ and ‘ORF1b’ which are encoded for 
non-structural proteins, could be up to 16. On the 3ʹ end, 
the structural gene region covers one-third of the 
genome, structural protein genes are encoded from 5ʹ to 
3ʹ as a spike, envelop, membrane, and nucleocapsid, 
respectively. Open reading frames are also nurtured by 
structural gene regions and are intermixed along with the 
coding genes of the structural proteins. Each coronavirus 
species has a distinct sequence and number of ORFs 
[20].  
In the previous two decades, two species of 
coronaviruses have crossed the species barrier, leading 
to the acute and lethal infection to humans, SARS-CoV, 
and MERS-CoV in 2002 and 2012, respectively [21]. The 
case fatality rate of SARS-CoV and MERS-CoV was 
noted comparatively higher than that of other common 
respiratory viral infections, 10 and up to 50%, 
respectively [22].  
MERS-CoV was first identified and reported to WHO 
in September 2012 [21]. The first human with the 
infection of “MERS-CoV” (Middle East Respiratory 
Syndrome) appears in Saudi Arabia during June 2012.  
The one was an old man of 60 years. He visited the 
hospital owing to pneumonia, while later, it was known to 
develop renal failure [23].  
The latent period of middle east respiratory syndrome 
coronavirus is two to fourteen days, with a median of 5.4 
days. It takes four days from the disease development 
and patients admission, the period when people die due 
to disease. It takes 11.5 days  [24]. Flue like symptom is 
observed in the first stage, including arthralgia, myalgia, 
fever, chilling, and coughing followed by the respiratory 
difficulty, which is quickly progressed to pneumonia [25]. 
The complaint of thirty percent of patients was to have 
bowel symptoms, including vomiting and diarrhea [26].      
Natural reservoirs of the “MERS-CoV” and SARS-like 
coronaviruses are Bats. However, there is a shred of 
evidence about a small number of camels found positive 
(positive nasal swabs by rtPCR) and the presence of 
antibodies against middle east respiratory syndrome 
coronaviruses. The route of transmission and the 
intermediate animal source remains uncertain among 
sporadic primary cases. Severe respiratory failure may 
occur due to both middle east respiratory syndrome 
viruses and SARS-CoV, which also causes 
extrapulmonary features like diarrhea, while mild and 
asymptomatic cases also present in both conditions. In 
contrast with SARS-CoV and patients with middle east 
respiratory syndrome, coronaviruses are older and male 
predominance more comorbid illness and comparatively 
lower transmission potential regarding humans to 
humans. Although viral kinetics of the middle east 
respiratory syndrome Coronaviruses remains unknown 
and nosocomial infection of MERS-CoV occurs early 
within 1st week of illness, while SARS-CoV in 2nd week of 
illness when the viral load peaks on in the upper airway 
of the patients on 10th day of the illness.  It is suggested 
by the in-vitro data that interferons with or without the 
mycophenolic acid and ribavirin may inhibit middle east 
respiratory syndrome Coronaviruses, while interferons 
and protease inhibitors also have inhibitory activity 
against the  SARS-CoV [23]. 
Globally 887 cases of middle east respiratory 
syndrome Corona Viruses infection confirmed by the 
laboratory were reported since 30 September 2014, and 
352 patients have died with 39.7% case fatality rate, 
97.5% cases were present in the Middle East including 
Saudi Arabia, Iran, Lebanon, Jordan, Yemen, Oman, 
Egypt, United Arab Emirates, Kuwait, and Qatar, among 
this 85.0% was reported in Saudi Arabia [27]. To closely 
monitor the “MERS-CoV” infections globally and to 
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understand the risks regarding public health in a better 
way, CDC is working with WHO and other partners.    
WHO confirmed the 956 cases (laboratory-confirmed 
cases) of Middle East respiratory syndrome Corona 
Viruses (MERS-CoV) with at least 351 casualties since 
23rd of January, 2015. All the reported cases were linked 
directly or indirectly through traveling or residential 
history to the 9 countries, including Saudi Arabia, Iran, 
Lebanon, Jordan, Yemen, Oman, Egypt, United Arab 
Emirates, Kuwait, and Qatar. Two patients were found 
positive to MERS-CoV infection since May 2014 in the 
United States, each of them showed a history of fever 
and one or more respiratory signs after their recent travel 
from Saudi Arabia. No further case of Middle East 
respiratory syndrome Corona Viruses infection was 
reported despite the nationwide surveillance and also the 
testing of 514 patients from the 45 states of the United 
States. The majority of the cases 504 out of 956 MERS-
CoV occurred during the month of March-May.  
However, WHO received the cases MERS-CoV 
infection mostly from Saudi Arabia from 1st august, 2014, 
through 23 January 2015, world health organization 
confirmed 102 cases out of these 97 cases occurred in 
the persons who were resident in Saudi Arabia, including 
three traveling histories of cases reported by Jordan, 
Austria and Turkey, two cases were reported from Qatar 
and three cases were reported from Oman [28].  
Transmission  
Primarily severe acute respiratory syndrome  is  
transmitted through contact or large respiratory droplets 
[29], limited airborne transmission [30]. No evidence of 
perinatal SARS infection among infants born to mothers 
who developed SARS infection during pregnancy [31].   
MERS-CoV infection suggests zoonotic transmission   
[32]. Secondary transmission  (human to human) [24]. 
Bats may be the ancestors of coronavirus [33]. MERS-
CoV causes a zoonotic infection, infects dromedary 
camels, and can be transmitted to humans through close 
contact [34]. SARS-CoV and MERS-CoV can be 
transmitted through symptomatic patients, not from 
asymptomatic or patients with no specific signs [35]. 
SARS-CoV was transmitted to humans from exotic 
animals in wet markets, while MERS-CoV is transmitted  
to humans from camels [36].  human hosts from Zoonotic 
reservoirs such as bats, raccoon dogs and Himalayan 
palm civets transmits SARS-CoV into human host [37].   
Risk of transmission of MERS-CoV infections is high in 
the health care workers who are in close contact with the 
patients and handling the biological materials such as 
faeces, blood, sputum, urine, and respiratory 
secretions[38]. 5% rate of secondary transmission of 
MERS-CoV infections is reported [39]; it can also be 
transmitted from human to human [40].  
Marburg virus 
In 1967, filovirus hemorrhagic fever first appeared in 
Germany and the former Yugoslavia. Marburg virus 
(MARV), the pathogen identified in this outbreak, is one 
of the deadliest pathogens in humans. [41]. The Ebola 
virus (EBOV) (organization, 1978) belongs to a well-
known family and first appeared in Africa in 1976. Shortly 
afterwards, Marburg and Ebola viruses were classified 
as a newly formed family called Filoviridae. It is called 
because of its characteristic filament structure (filum is 
Latin means thread). Between 1975 and 1985, MARV on 
the African continent caused only one outbreak, affecting 
a small number of people.  
Year(s) City Country 
Fatalities/ 
number of cases 
(case fatality 
rate) 
1967 Marburg Germany 5/24 (21%) 





1975 Johannes-burg South Africa 1/3 (33%) 
1980 Nairobi Kenya 1/2 (50%) 
1987 Nairobi Kenya 1/1 (100%) 
1988 Koltsovo 















Republic of the 
Congo 
128/154 (83%) 
2004-2005 Uíge Angola 227/252 (90%) 




USA 0/1 (0%) 
2008 Leiden Nether-lands 1/1 (100%) 
Total   368/452 (81%) 
Table 1: Marburg virus disease outbreaks. History of all 
laboratory confirmed MVD cases [41].  
Because the case fatality rates associated with MVD 
were lower than 90% of the catastrophic outbreaks 
associated with EBOV, the threat of MARV has not been 
considered for a long time. MARV reemerged between 
1998 and 2000. Two major outbreaks: Democratic 
Republic of the Congo (DRC), 2004-2005 [42], and First 
time in Angola in West Africa [43]. A total number of 
cases more than four hundred with high case fatality 
rates >80% in DRC and up to 90% in Angola depicts that 
MARV was a major public health threat like EBOV  [44].   
According to the World Health Organization (WHO), 
the mortality rate at the first outbreak was 25%, 
compared to the Democratic Republic of the Congo 
between 1998 and 2000 and more than 80% in Angola 
in 2005. 
Transmission  
Filoviruses categorized as the deadliest zoonotic viruses 
known to infect human beings [45]. Marburg virus infects 
humans sporadically [46]. There is no evidence of 
transmission by asymptomatic patients. The chance of 
transmission without direct physical contact is very low 
but not zero [47].  Risks of transmission increase 
dramatically by visiting and caring for filovirus cases in 
hospitals. Earlier hospitalization and longer stay 
providing isolation and protection can shorten the 
periods of filovirus outbreaks [47], can transmit human to 
human [48]. Possible sexual transmission of Marburg 
Virus has been reported [49]. Infection can be 
transmitted due to funeral related events [50]. 
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Ebola virus 
The first Ebola outbreak in Sudan and the Democratic 
Republic of the Congo in 1976 was stuck in humans [51]. 
The Ebola outbreak in West Africa was the 25th known 
outbreak since 1976, but radically different from all 
previous cases  [52]. Transmission of the Ebola virus 
occurs via body fluids or tissues of infected individuals. 
According to Milberger, the deadlines of known strains 
varies widely. Ebola Reston is a nonpathogenic strain. 
As of 31 March 2020, a total of 3453 EVD (Ebola virus 
disease) cases were reported from 29 health zones 
including 3310 confirmed and 143 probable cases, of 
which 2273 cases died (overall case fatality ratio 66%). 
Of the total confirmed and probable cases, 56% (1935) 
were female, 28% (979) were children aged less than 18 
years, and 5% (171) were healthcare workers. 
Transmission  
The Ebola virus outbreaks were associated with bush 
meat and fruit bats handling [46]. Filovirus infection is 
primarily transmitted through close contact or later 
stages of illness[47], infected patients, body secretions 
including sweat and breast milk, and excretions including 
semen, vomit, stool, urine [53], broken skin, mucous 
membrane, contaminated syringes [47], transmits to 
human by the freshly killed bats consumption [54], 
hunting and butchering of monkeys, chimpanzees, 
duikers and gorillas for food [55]. Isolation of the Ebola 
virus 82 days and detection of viral RNA 101 days after 
the onset of symptoms has been reported [56].  There is 
evidence of sexual transmission and persistence of 
infective Ebola virus in semen for 179 days or more after 
the onset of Ebola virus disease (EVD) [57]. Ebola Virus 
survivors should avoid unsafe sex until more information 
about the shedding of the infectious virus through body 
fluids is known. A male survivor should use condemn 
every time for safe sex (oral, vagina, anal) [58]. There is 
circumstantial evidence of aerosol transmission during 
EBOV outbreak (1995) in the democratic republic of 
Congo that has been reported [59].   
Rabies virus  
Rabies (acute encephalitis) caused by Lyssavirus of 
Rhabdoviridae family, rarely infects human, transmits 
from an organ donor to multiple recipients [60]. 
Lyssavirus is one of the seven genera of the family 
Rhabdoviridae family, order Mononegavirale. It 
comprises of RABV; genotype 1 (classical rabies virus), 
LBV; genotype 2 (Lagos bat virus), MKV; genotype 3 
(Mokola virus), DV; genotype 4 (Duvenhage virus), 
EBLV-1; genotype 5 (European bat lyssavirus 1), EBLV-
2; genotype 6 (European bat lyssavirus 2), and ABLV; 
genotype 7 (Australian bat lyssavirus). Four additional 
viruses are also isolated from insectivorous bats and 
proposed as new members of the Lyssavirus genus: 
Aravan virus, Khujand virus, Irkut virus, and West 
Caucasian bat virus [61].  
Transmission  
Non-bite transmission is very rare, and aerosol 
transmission has never been well documented  [62]. 99% 
of humans death due to rabies occurs due to domestic 
dog [63],  infected peoples (secretions) may be a 
potential risk [64]. The virus is inoculated by the biting of 
rabid animals (virus-laden saliva) into muscles 
subcutaneous tissues [65], through wounds, direct 
contact with the mucosal surface and it cannot cross 
intact skin. Risk of rabies infection by a bite is 5%-80% 
which is at least 50 times greater than that by a scratch 
0.1%-1%, Mortality after untreated bites by rabid dogs 
ranges from 38% to 57%  [66]. Bat virus might be more 
infectious than dogs [67]. 
The rabies vaccine was introduced in the 1920s 
because of its use in domestic animals number of cases 
was exceedingly reduced in developed countries, but it 
remained a significant issue in African and some Asian 
countries. This was the first outbreak of rabies 
transmitted by vampire bats in Brazil, where the rabies 
virus was isolated from humans and bats [68]. Bats have 
spread rabies outbreaks in several remote locations in 
Peru [69], Venezuela [70], and Brazil [71]. 
HIV (Human immunodeficiency virus) 
Human immunodeficiency virus (HIV-1) belongs to the 
retroviridae family and is a causative agent of acquired 
immunodeficiency syndrome, more than 30 antiviral 
drugs have been invented [72]. These antiviral drugs 
help infected patients with HIV to live even for years. But 
the destruction of this disease being continued in middle 
and low-income countries in which more than 90% of 
new cases of HIV occur. According to WHO, 5% of the 
population of African countries is HIV-positive. HIV 
infection was diagnosed in 135 patients out of 4200 
papulation on April 21st by ISDH (Indiana State 
Department of Health), out of them, 129 were confirmed 
positive while 6 cases were preliminary positive with 
rapid HIV testing and their confirmatory testing was 
pending. Confirmed (135) patients range between 18-57 
years of age with 35 years mean and 32 years of the 
median.  The percentage of male patients (55%) was 
higher than that of female, and no infant was declared as 
HIV positive. Antiretroviral therapy was recommended 
for pregnant HIV women patients during pregnancy. Out 
of all the confirmed cases, 80% were those having 
injection drug use (IDU) history, only 3% with no IDU 
while remaining have unknown IDU status.  
Transmission  
The process of HIV transmission, establishment, and 
dissemination remains unclear in human beings for thirty 
years after its discovery [73]. The gender relatedness of 
women makes them at high risk directly or indirectly to 
HIV. The statistical analysis of HIV depicts an alarming 
situation. According to a survey of the World Health 
Organization up to 10 million people were infected in jolly 
1990 round the globe[74]. People who are infected with 
HIV are often held responsible for their condition. 
Because HIV is infected with behaviours that people 
think they can avoid: unsafe sex and irrational drug use 
[75]. The stigma of AIDS is also closely linked to other 
stigma related to dangerous behaviours, such as sexual 
temptation, homosexuality, intercourse, and drug use. 
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HIV-infected people with sexual and narcotic effects 
have the greatest side effects compared to people 
infected with blood transfusions [76]. 
 
Smallpox 
Natural pox is the main biological, social, and spatial 
factor that affects the spread of disease in modern 
populations, and it has been largely elucidated based on 
historical research before the disease was eliminated in 
1979 [77]. Even after the eradication of smallpox, it is a 
continuous risk for humanity until laboratory stocks of 
virus vanished [78]. Some Preliminary reports that the 
outbreak of smallpox in the former Soviet Union in 1971 
was triggered by field trials with secret biological 
weapons led to intense debate and several 
uncomfortable steps among a small group of 
bioterrorism experts. Outbreaks indicate that a natural 
smallpox aerosol attack could indeed be fatal, 
suggesting that the Soviet Union turned the extremely 
deadly effects of natural smallpox into a weapon [79]. 
Contingency arranging for the plausible intentional 
reintroduction of natural smallpox has been a priority for 
many national health authorities in recent years [80]. 
Tracked vaccination policy has been integrated into a 
natural smallpox transmission model to approximate the 
number of suspected cases and deaths from 
agglomeration attacks. If we compare the results from 
the time the seizures were detected with mass 
vaccination, we see that mass vaccination leads to far 
fewer deaths and much faster epidemic eradication for a 
variety of diseases and intervention guidelines. Mass 
vaccinations, including those considered the most likely, 
also go beyond current policies and begin tracking 
vaccinations and switch to mass vaccination only when 
needed [81]. 
World Health Assembly proclaimed the globe free from 
smallpox in 1980. But before the eradication of disease, 
it makes several attacks on humans over thousands of 
years, and smallpox killed humans with a 33% case 
fatality rate, those who survived have to suffer scars and 
blindness permanently. Non-European populations have 
a higher mortality rate, and the virus is little exposed until 
tourists bring it to the region. For example, according to 
an estimation, the death of 90% American native 
population from smallpox occurred due to European 
researchers. Three hundred million people were died by 
smallpox only in the 20th century. Smallpox was a 
massive burden on the earth, not only because of 
mortality but also scars and blindness, which stimulate a 
campaign for its eradication from the earth. 
Transmission  
First outbreak of smallpox in Bradford was reported in 
1942  [82] and 1962 in Edinburgh. The initial 
reproduction rate of smallpox is 2 [83], which is reported 
different in other breaks. Before the eradication of 
smallpox, it was a directly transmitted respiratory 
disease caused by the variola viruses, the mortality rate 
in 1974 was 26.5% among the unvaccinated in India [80]. 
Variola aerosols produced a disease that simulated 
human smallpox  [84]. Transmission throughv casual 
contact is very rare  [85].  
Hantavirus 
This virus belongs to the family Bunyaviridae and is 
nurture from martyred rodents. Infected rodents are 
reservoir host, and they excrete viruses through body 
secretions and excretions like saliva, urine, and faeces. 
Deer mouse (Peromyscus maniculatus) is a reservoir 
host for Sin Nombre orthohantavirus [86]. A zoonotic 
disease which is rodent born, Hantavirus 
cardiorespiratory syndrome (HCPS) is an endemic 
disease of America and confined there for several 
decades. According to a hypothesis, precipitation was 
increased due to El Nino southern oscillation providing a 
favourable environment that allowed a rise in rodent’s 
population, increasing its risk of zoonotic transmission in 
1991-1992. This transmission possibly results in the 
HCPS outbreak between 1993-1994 at each corner of 
the southwestern United States [87]. A total of 52 
patients were affected by HCPS in the 1993 outbreak 
that was continued up to 1994. These cases were 
reported sporadically in a four-cornered state and 
elsewhere in the USA. An average of four cases were 
reported annually from 1995-1997 in the United States 
[87]. 
Ample attention was gained by HPSC first time in the 
United States when a young man with his fiancée was 
died within a few days due to breathing shortness, from 
a four-cornered area in 1993. Few months after the death 
of a young man Hantavirus was isolated from deer 
mouse from the house of that affected person by health 
authorities. According to the reports of the Center for 
Disease Control and Prevention total of 600 people were 
affected by HPS in the U.S and out of the 216 were died 
with a 36% case fatality rate. According to the Federal 
Infection Protection Act in Germany, Hantavirus clinical 
cases have been reported since 2001 majorly due to the 
Puumala virus (PUUV) along with two other viruses, 
Dobrava-Belgrade and Tula [88].  
On average, 220 cases of HPSC were reported each 
year from 2001-2006 with the highest 448 patients in 
2005 [89]. While 1687 cases were confirmed in 2007 
[89]. Droppings from infected mice are the main source 
of infection, from which infection spreads person to 
person. There was a previous outbreak of Hantavirus 
during the Korean War in the 1950s, reported in the 
review paper of journal Clinical Microbiology 2010. In this 
outbreak, 3000 soldiers were infected, and 360 have 
died with a 12% case fatality rate. At that time Hantavirus 
was a novel infection for U.S researchers, later on, its 
relation with deer mice was determined by Navajo 
medical traditions by detecting a similar disease. 
Transmission  
In 1993 Hantavirus pulmonary syndrome was 
recognized in united states for the first time it is a rodent-
borne zoonosis [90]. Person to person of Hantavirus is 
reported [91].        Direct contact is not necessary for the 
transmission of Hantavirus between the rodents or 
rodents and humans, it can also be transmitted 
horizontally. Transmission rate becomes least 
dependent on the host density while increases the 
persistence in host population in case of indirect 
transmission [92].
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Influenza Virus 
Periodic and frequent epidemics caused by the Influenza 
virus is a major health issue. In 1918, 1957, 1968, 1977 
pandemics of swine influenza, Asian influenza, Hong 
Kong influenza, Russian influenza occurred due to the 
type A antigenic variation of influenza virus. Due to minor 
antigenic variation in the strains of pandemics frequent 
epidemics may occur. Type A (H1N1) and A (H3N2) 
strains with minor antigenic variation and type B 
influenza virus is currently circulating worldwide causing 
frequent epidemics. Influenza virus belongs to 
Orthomyxoviridae family, having medium size 80–120 
nm and three immunologic types: A, B, and C. Type A 
virus which is a major cause of disease outbreak 
(epidemics, pandemics) show antigenic variation 
continuously [93]. 
According to the WHO's, more than 500,000 people 
around the world die from the disease during a typical 
season of flu. Occasionally, however, a new strain of 
influenza appears, and a pandemic spreads the disease 
faster, often leading to higher mortality percentages. The 
most lethal pandemic influenza called Spanish flu that 
began in the 2nd decade of the 20th century and affected 
the 40% population worldwide. According to estimation, 
50 million people have died during this outbreak. 
Transmission  
Influenza viruses can be transmitted through aerosols, 
large droplets, or direct contact with secretions (or 
fomites), aerosol transmission [94]. Large-droplets are 
the predominant mode of transmission of influenza virus 
infection [95], Coughing or sneezing [96]. 
Dengue virus 
Dengue is a mosquito born emerging viral infection which 
is life threatening. There are four serotypes of Dengue 
virus including DENV-1, DENV-2, DENV-3 and DENV-4. 
Approximately 96 million clinical cases of dengue cases 
occur per annum throughout the world [97]. The first 
outbreak of the Dengue virus appeared in Thailand, and 
the Philippine in the 1950s then spread to the tropical 
and sub-tropical regions of the world. Global warming is 
enhancing the risk of disease transmission with carrier 
mosquitoes. Currently, the Dengue virus is endemic in 
the world’s 40% population area.  The disease caused 
by this virus called ‘dengue hemorrhagic fever’ having 
some similarity with Ebola virus infection. Its mortality 
rate is 2.5%, slightly lower than some other deadly viral 
infections, but it could rise to 20% if left untreated. 
“Dengue is a real threat for humanity, and we have to 
take some practical steps against it,” Muhlberger said. 
Till now, there is no vaccine against this disease, some 
positive clinical results have obtained by French drug 
maker Sanofi. 
Transmission  
Dengue is a mosquito-borne viral infection [98], caused 
by four virus serotypes (DENV-1, -2, -3, and -4), 
primarily transmitted by day-biting of Aedes aegypti [99], 
having a short flight range [100, 101]. The dengue virus 
transmission is sensitive with seasonal variation as 
temperature changes affect the transmission of vector-
borne viral disease and epidemic potential by the 
vector’s reproductive rate, length of EIP (the extrinsic 
incubation period), and biting rate [102]. Dengue virus 
can be transmitted without vector mosquito, needle stick 
injuries, vertical transmission, intrapartum, bone marrow 
transplantation and blood transfusion [103]. It is highly 
anthropophilic and breeds in water storage drums, 
bottles, buckets, discarded waste items, and over 
headed tanks [104]. Dengue is of particular importance 
in Asia [105]. Virus transmission increases with the 
increase of human population density.  In cities, the 
movement of viraemic persons is a more important 
means of transporting dengue viruses as compared to 
the movement of Ae. aegypti mosquitoes [101]. 
Rotavirus 
Rotavirus is a non-enveloped double-strand RNA virus. 
114 million cases of rotavirus infection and more than 
200000 deaths of children were reported worldwide in 
2003 [106]. According to an estimation, 138 million cases 
and 215000 deaths annually were reported in children of 
age less than five years, in developing as well as in 
developed countries mainly in Asia and sub-Saharan 
Africa  [107]. According to Rotavirus surveillance data 
(2008-2018) 40.78% children out of all diarrheal disease, 
children was infected with Rotavirus infection in 
Southeast Asia [108]. 
Rotavirus, another deadly viral threat mainly for 
children, one of the most leading causes of severe 
diarrhoea in young ones. Its transmission occurs through 
feco-oral route. Although two types of vaccines are 
available against this disease but the death of affected 
children occurs in developing countries due to a lack of 
rehydration facilities. But its mortality rate is very low in 
the developed world due to better treatment. 
Rotavirus outbreak in 2008, up to half a million children 
were died worldwide, according to the World Health 
Organization. But a sudden decline in mortality rate has 
been reported in countries, where proper vaccination 
against rotavirus was done. 
Transmission  
Rotavirus can be transmitted through feco-oral route, 
and it can also be transmitted through direct contact with 
the contaminated surfaces, respiratory spread, 
contaminated hands. Other gastrointestinal infectious 
agents are transmitted through fecal-oral route, food may 
transmit such type of pathogen irrespective to this 
rotavirus spread in all home or day care centre not only 
the areas which are contaminated with stool [109]. A 
children with Rotavirus infection can excrete 100 billion 
virus particles in 1 g of stool. [110]. In hospitals rotavirus 
can be transmitted through aerosol transmission, and is 
detected in the respiratory secretions of some 
patients[111]. Investigators have found rotavirus on 
hand washing areas, faucet, toys, food preparation 
areas, diaper disposal containers and diaper changing 
areas [112].  It is also reported that asymptomatic 
patients can also transmit or shed Rotaviruses [113].  
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Economic impact  
The outbreak of Ebola virus initially reported in Guinea in 
2014 than spread to other West African nations like 
Liberia, Sierra Leone, and Guinea. The case fatality rate 
of this lethal virus was its major scare, 42-66% (World 
Health Organization, 2014). Due to high fatality and 
transmission rates, the borders of affected countries 
were sealed in July 2014, resulted in a negative impact 
on the economy. Agriculture and mining sectors are 
major contributors to GDP, 25% and 17% respectively in 
West African countries, and their production was 
slumped from 30-60% due to viral outbreaks [114].  
According to an estimation, a total of $2.8 billion 
shrinkages in the economy of West African countries was 
produced because of the Ebolavirus outbreak in 2014 
(World Bank).   
Rabies is another disease of economic and public 
health significance around the globe. Its economic loses 
are more in developing and underdeveloped countries. 
Major economic losses are divided into three categories, 
i.e. direct losses, indirect and DALYs (disability-adjusted 
life years). DALYs loses are because of dog bites ($1.8 
M) while their cumulative effect on vaccination, testing, 
and other effects on livestock and pets makes $5.5 billion 
per year[115]. Human mortality risk associated cost is a 
major burden on the global economy comprises of 
$1.2billion per year [114]. 
Human immunodeficiency syndrome virus (HIV) is a 
contagious and lethal virus throughout the world. It has 
diverse effects on the economy, according to a study 
there will be 0.56-1.08% drop in GDP of 30 African 
countries from 1990 to 2025[116]. In the United States, 
its economic impact is more scare, antiretroviral therapy 
against HIV costs $256 billion at the present level for 
previous years. This huge treatment cost reveals its 
economic importance [116]. Smallpox, a zoonotic 
disease of agricultural importance also played a diverse 
role against an economy in the history of mankind, its 
complete eradication costs $300 million in 10 years 
duration [117]. 
In the 20th century, there were three major pandemic 
outbreaks of Influenza (1918, 1957 and 1968)[118]. Its 
economic impact on the low fatality scenario was $68.2 
billion while $88.9 billion for a high fatality scenario only 
in the United Kingdom [119]. The 21st century has seen 
a modified form of Influenza A subtype H1N1 severe 
acute respiratory syndrome (SARS) in 2003 and H5N1 
(bird flu) in 2009.  
Dengue is a mosquito-borne pandemic occurring in 
more than 100 countries all over the world. Its economic 
impact can be estimated that it costs $94.8 million per 
year only in Vietnam [120] and $169 million over 10 years 
between 2000-2015 in Brazil [121]. 
 Diseases of GIT remains fifth and 2nd major cause of 
mortality and morbidity respectively in children’s of less 
than 5 years around the globe, rotavirus (norovirus) is 
one of them [122]. Globally, a total of 64.5 billion per year 
economic impact of norovirus, 4.2 billion covers direct 
health system cost while 60.3 billion is a societal cost 
[122].  
The Middle East respiratory syndrome (MERS) 
outbreak in 2015 caused a total of $3.1 billion loss to the 
economy of Republic of Korea which indicates that public 
health emergencies due to outbreaks of contagious 
diseases may cause significant losses to the economies 
of affected countries [123]. COVID-19 may prove highly 
contagious economically as it is medically. The 
economic impact of this pandemic virus is far more than 
any previous outbreak. Its economic disruption is 
because of travel restrictions, factories closure, 
quarantines, and most effectively lockdown along with 
the direct impact on human health (economic in Time of 
COVID-19). According to an estimation, the global 
workforce may lose $3.4 trillion in 2020 because of the 
COVID-19 outbreak (International labor organization) 
(Figure 2). 




Ebolavirus West Arica, $2.8 bn  [114]  
 (World Bank) 
Rabies 195 countries $125.5 bn/annum [124] 
 




Smallpox USA $30 M/annum [117] 
 
Influenza UK $68.82 bn [119] 
 
Dengue Vietnam $94.87M/annum [120] 
 
Rotavirus Worldwide $64.5M/annum [122] 
SARS Worldwide $40 bn/annum [126] 
MERS ROK $3.1bn/annum [123] 
COVID-19 Worldwide $1.1tn The Guardian 
Table 2: Impact of pandemics on the economy  
 
Figure 2: Estimated loss in worldwide labor income in COVID-19 
pandemic  
Conclusion 
According to an estimation, $2.8 billion shrinkages in the 
economy of West African countries due to Ebolavirus 
outbreak in 2014, Rabies vaccination, testing, and other 
effects on livestock and pets makes loss of $5.5 billion 
annually, Human mortality risk associated cost is a major 
burden on the global economy is $1.2billion/ annum due 
to rabies. All viral outbreaks, including Marburg virus, 
HIV, Smallpox, Hantavirus, Influenza, Dengue, Rotavirus 
causes major loss of global economy. The global 
workforce may lose $3.4 trillion in 2020 due to COVD-19 
pandemic. COVID-19 disease is a potentially fatal 
disease of global health concern that can be transmitted 
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easily through aerosol transmission, direct contact, 
human to human and through secretions. Transmission 
of COVID-19 virus through asymptomatic patient is also 
a major threat. The COVID-19 pandemic showed us the 
immense economic cost of slowing down global trade, 
particularly shipping. It also reveals how dependent on 
the global supply chain we are, even for medical supplies 
such as masks and test materials. Due to the easy 
transmission of viral infection and fast spreading 
capability and high pathogenicity, viral outbreaks are the 
major threat for the modern world. The cases of COVID-
19 are increasing day by day and a great threat to the 
world economy. Underdeveloped countries having 
inadequate healthcare facilities are going to be 
destroyed. Trade has stopped all over the world, 
implementation of curfew and lockdown in most of the 
countries indicates that despite having low case fatality 
rate, coronavirus (COVID-19) outbreak is going to be 
worse than ever before.  
Future research should focus on the prevention of 
transmission of viruses rather than finding the cure of the 
disease or making an effective vaccine because the cost 
of vaccine and treatment results in an economic burden 
on the state. This could only be achieved by adopting the 
One Health approach. It is an integrated approach that 
enables workers of human health, animal health and 
plant to work mutually to achieve this goal.  
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